Trial intelligence / Profile preview

Avastin in Locally Advanced Cervical Cancer

NCT04138992Phase 3Unknown

Sponsor
Air Force Medical University
Start
Aug 2020
Primary completion
May 2021
Modality
Monoclonal Antibodies
Countries
1
01

Overview

A Phase 3 trial of bevacizumab in Cervical Cancer (CC), sponsored by Air Force Medical University. Status: unknown.

02

Drugs

bevacizumab
03

Conditions

Cervical Cancer (CC)

Beyond the preview

Go deeper on NCT04138992.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04138992.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call